These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 32738379)
1. A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitis. Akkol EK; Karpuz B; Sobarzo-Sánchez E; Khan H Food Chem Toxicol; 2020 Oct; 144():111628. PubMed ID: 32738379 [TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Fernández-Bañares F; Hinojosa J; Sánchez-Lombraña JL; Navarro E; Martínez-Salmerón JF; García-Pugés A; González-Huix F; Riera J; González-Lara V; Domínguez-Abascal F; Giné JJ; Moles J; Gomollón F; Gassull MA Am J Gastroenterol; 1999 Feb; 94(2):427-33. PubMed ID: 10022641 [TBL] [Abstract][Full Text] [Related]
3. Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis. Iqbal U; Anwar H; Quadri AA Am J Med Sci; 2018 Oct; 356(4):350-356. PubMed ID: 30360803 [TBL] [Abstract][Full Text] [Related]
4. How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis? Ardizzone S; Porro GB Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S238-9. PubMed ID: 18816705 [No Abstract] [Full Text] [Related]
5. Is maintenance therapy always necessary for patients with ulcerative colitis in remission? Ardizzone S; Petrillo M; Imbesi V; Cerutti R; Bollani S; Bianchi Porro G Aliment Pharmacol Ther; 1999 Mar; 13(3):373-9. PubMed ID: 10102971 [TBL] [Abstract][Full Text] [Related]
7. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Sutherland L; Macdonald JK Cochrane Database Syst Rev; 2006 Apr; (2):CD000544. PubMed ID: 16625537 [TBL] [Abstract][Full Text] [Related]
8. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Sutherland L; Roth D; Beck P; May G; Makiyama K Cochrane Database Syst Rev; 2002; (4):CD000544. PubMed ID: 12519547 [TBL] [Abstract][Full Text] [Related]
9. 5-Aminosalicylic acid, a specific drug for ulcerative colitis. Hauso Ø; Martinsen TC; Waldum H Scand J Gastroenterol; 2015 Aug; 50(8):933-41. PubMed ID: 25733192 [TBL] [Abstract][Full Text] [Related]
10. Encapsulated mesalamine granules (Apriso) for ulcerative colitis. Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588 [TBL] [Abstract][Full Text] [Related]
11. [Remission of ulcerative colitis after appendectomy: a case report]. Noh CH; Cheung DY; Kim TH; Jun EJ; Lee IK; Kim JI; Cho SH; Park SH; Han JY; Kim JK Korean J Gastroenterol; 2010 Sep; 56(3):201-4. PubMed ID: 20847611 [TBL] [Abstract][Full Text] [Related]
12. Mesalamine for inflammatory bowel disease: recent reappraisals. Actis GC; Pazienza P; Rosina F Inflamm Allergy Drug Targets; 2008 Mar; 7(1):1-5. PubMed ID: 18473894 [TBL] [Abstract][Full Text] [Related]
13. What is the optimal maintenance treatment for ulcerative colitis? Cohen RD Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S236-7. PubMed ID: 18816679 [No Abstract] [Full Text] [Related]
14. Can we move directly from 5-ASA to a biologic agent in ulcerative colitis? Hindryckx P; Novak G Best Pract Res Clin Gastroenterol; 2018; 32-33():9-15. PubMed ID: 30060944 [TBL] [Abstract][Full Text] [Related]
15. [Curcumin add-on therapy for ulcerative colitis]. Salomon N; Lang A; Gamus D Harefuah; 2015 Jan; 154(1):56-8, 66. PubMed ID: 25796678 [TBL] [Abstract][Full Text] [Related]
16. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046 [TBL] [Abstract][Full Text] [Related]
17. Mesalamine with MMX technology for the treatment of ulcerative colitis. Schreiber S; Kamm MA; Lichtenstein GR Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):299-314. PubMed ID: 19072380 [TBL] [Abstract][Full Text] [Related]
18. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease. Bonapace CR; Mays DA Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055 [TBL] [Abstract][Full Text] [Related]